These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8093290
1. Post-marketing experience with live oral Ty21a vaccine. Cryz SJ. Lancet; 1993 Jan 02; 341(8836):49-50. PubMed ID: 8093290 [No Abstract] [Full Text] [Related]
7. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Begier EM, Burwen DR, Haber P, Ball R, Vaccine Adverse Event Reporting System Working Group. Clin Infect Dis; 2004 Mar 15; 38(6):771-9. PubMed ID: 14999618 [Abstract] [Full Text] [Related]
10. Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Arya SC, Agarwal N. Vaccine; 2014 Jul 07; 32(32):4013. PubMed ID: 24831232 [No Abstract] [Full Text] [Related]
14. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. Ferreccio C, Levine MM, Rodriguez H, Contreras R. J Infect Dis; 1989 Apr 07; 159(4):766-9. PubMed ID: 2647863 [No Abstract] [Full Text] [Related]
15. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever. Wu Y, Chakravarty S, Li M, Wai TT, Hoffman SL, Sim BK. J Infect Dis; 2017 Jan 15; 215(2):259-268. PubMed ID: 27803169 [Abstract] [Full Text] [Related]
16. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Lundgren A, Sack DA, Svennerholm AM, Qadri F. Vaccine; 2014 Feb 19; 32(9):1055-60. PubMed ID: 24440210 [Abstract] [Full Text] [Related]